Target intelligence / Profile preview

Collagen fiber formation

Molecular classification
Other (biological process)
01

Overview

Collagen fiber formation is not a single molecule or receptor but rather a complex biological process involving the synthesis, assembly, and maturation of collagen molecules into higher-order structures called fibers. This process begins with the intracellular synthesis of procollagen in fibroblasts and other specialized cells. Procollagen undergoes post-translational modifications such as hydroxylation (requiring vitamin C) and glycosylation before being secreted outside the cell[1][7]. Once extracellular, procollagen is cleaved to form tropocollagen, which then self-associates into fibrils through covalent cross-linking—primarily via lysyl oxidase-mediated reactions[1][7]. These fibrils further aggregate into larger fibers that provide structural strength to tissues such as skin, bone, tendon, cartilage, and blood vessels[2][6]. The regulation of this process depends on genetic factors (mutations can cause diseases like Ehlers-Danlos syndrome), environmental influences (such as UV exposure or smoking), nutritional status (notably vitamin C), and enzymatic activity. Disruption at any stage can result in weakened connective tissue structure or pathological fibrosis[5][7]. Because "collagen fiber formation" refers to a process, not a discrete molecular target like an enzyme or receptor protein, it is not considered a direct therapeutic target for drugs; rather, individual enzymes involved in this pathway—such as prolyl hydroxylase or lysyl oxidase—may be targeted indirectly for therapeutic purposes. > "Collagen fiber formation" should not be listed as a canonical drug target; instead focus should be placed on specific enzymes or proteins within this pathway if relevant for drug discovery efforts.[1][3][5]

Other names
Collagen fibrillogenesisCollagen fibril assemblyCollagen fiber maturation
02

Biological functions

Structural supportTissue integrityWound healing
03

Disease associations

Connective tissue disorders (e.g., Ehlers-Danlos syndrome, osteogenesis imperfecta)Skin agingFibrosis
04

Safety considerations

Impaired collagen formation can lead to fragile tissues and poor wound healing
05

Biomarkers

Decreased collagen content (marker of aging or connective tissue disease)

Beyond the preview

Go deeper on Collagen fiber formation.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Collagen fiber formation.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call